Selling the Frenzy

I am raising cash here because I don’t have any place to put money. Nothing is screaming out to me now, so I might as well take a breather.

Aside from RPTP, there is another biotech that I am very interested in; but it’s up a lot today and I was hoping to buy it lower.

Having said that, the market looks great and there isn’t a reason to sell now. I tend to get uneasy when stocks become very predictable. Also, the last thing in the world that want to do is ride these suckers into earnings.

No thanks.

I am not a stupid man. Therefore, I am taking some profits here, selling TXTR post recovery. I have no interest in battleground stocks when everything is trading up.

Sellers of ICPT got it wrong.

When I asked my expert source about ICPT at $40, he laughed and said their liver drug was “impossible.” Well, studies have proved him wrong and he’s acknowledged the huge potential in NASH. A few days ago, there was some news out that said ICPT’s drug might cause a “fatty liver.” Look, I only play Doctor on the internets, doing surgery for fun because they gave me a scalpel. I don’t pretend to know the first thing about biotech. I am fully dependent upon real doctors with real degrees from North America. But ICPT is going to break $800 one day– and anything that works with their drug will run in tandem. WRITE IT DOWN!!! (screaming at the top of my lungs, despite it being very early in the morning)

It just so happens that RPTP has such a wonderful drug.

2014 is “The Year of the Liver.” While you wrestle with your erectile dysfunction issues, real people are in need of real livers, mostly due to alcohol abuse and/or excessive ingestion of harsh chemicals like “green tea.” We all need livers and would like to drink and smoke, AD HOC, without having to worry about superfluous liver enzyme issues, which may or may not lead to death.

As I write this, that stupid bastard, Mr. Wonderful from “The Shark Tank”, is on the teevee and that annoys me. I’ve lost interest in continuing this post.

Top pick: RPTP

You lost a great deal of money today. You are probably wondering why I still bother addressing the bears, men like Jennifer cavorting about the internets, warning people of impending doom. The truth is, I rather enjoy poking fun at you, the stupidest people of society, clad in burlap garments and velcro laced sneakers–because laces are simply “too hard”.

This is easy. Buy the dips and drink the blood. Spend your money judiciously and save for a rainy day.

The skies are clear now and the sun is electrifying, in the middle of winter, burning melanoma into the skin of the unprotected.

I bought GOGO towards the end of the day and will buy more if it hits $20.

NOTE: RPTP is now my largest holding.

Chartsists hate it. I like it.

I added to my position sub $23.

You didn’t think the market would trade lower again, did you?

You make this too easy for me. It’s like stealing the false teeth from an old lady in a wheeled chair at a red light. The NASDAQ is flying and my positions, save GOGO, are punching higher. I’ve made back plenty of losses and am now well on my way towards victory, of the unadulterated sort–if there is even such a thing.

From the watch list, CLDX is ripping bras and breasts off.

Look at TXTR, in all of its sublime grandeur, crushing the minds and spirits of the lemonade salesmen over at Citron Research. And, again, have a quick glance (DO NOT STARE!!!) at my RPTP, which has been my 2nd largest position for several days now.

Lastly, take out your “beer goggles” and have a gander at BALT, up on the day, even though Capesize rates have basically dropped to nothing, fulfilling the prophecy of Jennifer, yet no one seems to care.

I am always on the lookout for “the next big thing.” Right now, I happen to be distracted by biotech hand-grenades. But, at my core, I am a tech man–always have been since birth. On occasion, I venture off to the coal mines of West Virginia or delve into a little black gold in the Permian Basin. But at the end of the day, “The Fly” circles back to the technology space.

Courtesy of The PPT, here are the highest growth stocks (35%+) in tech, with earnings per share growth in excess of 10% and within 10% of a 52 week high.

CMGE
UBNT
DATA
JRJC
GOMO
SYNA
ENV
FB
CRTO
SPRD
LRAD
CSIQ
P
DDD
SILC
SPA
MONT
SFUN
OESX
YNDX
SBAC
ACIW
BITA

And here is a screen that searches for growth of 50%+ in tech, without earnings consideration or share price performance. Pure growth, unadulterated, if there is even such a thing.

January can usher in true deacons of death; but it’s not gonna happen in 2014. Don’t ask why. Worst case scenario, the market bugs out and we slide another 3%, closing out the month -3.5% for the month. Oh the tragedy!

Bear in mind, if we go down in January, we’re gonna forklift in February. There’s no escaping this brazen bull market. It’s the sort of beast that roasts you alive and you’d be the better for it.

Don’t bet against The Beard and it’s probably not a good idea to bet against “YaYo Yellen.” Not only is she a dwarf-like woman/creature, occupying the seat of legend, controller of the monetary base aka “The Devil,” she needs to make her mark immediately–else be considered a mistake.

You wouldn’t like to be called a mistake, would you?

There’s no point giving picks this evening, as I am likely to change my mind as I go. Sure YELP is interesting 10 points lower and I certainly like a biotech hand-grenade, every so often. But my current positions suit me just fine.

You won’t hear me repine, following a +70% year, while starting January with a graceful +4% start.

I have cash of about 12%, from last week’s sales. I was 130% leveraged long, so I have plenty of ammunition.

The market sells off, in good olde fashioned tumultuous nature, and the lot of you are scurrying about, falling off the sides of the ship. Many an expert on Twitter today professing to take “proper risk management” now that the market has “reversed and gone lower.” You stupid knave. Nothing has changed but the date on the calendar.

Didn’t I tell you January would be slightly lower, followed by a maganimous February?

I promise you if you bet against this tape, in an aggressive way, you are going to regret it.

As for me, I yawned at today’s decline and relish in the idea of buying BALT, post Capesize rate collapse, which closed a tad above $13,000. WOW! My positions in TXTR and GOGO took the edge off of today’s decline and I remain, ever so steadfastly, in the corner of the bulls.

I can’t understand what the hell these companies do!

For the life of me, I read through their statements and listened to their conference calls; but it’s all mumbo gumbo–frankly. Biotechs are nothing more, or less, than high stake gambles. The scientists assigned to these companies couldn’t care less about share prices and don’t mind sending in drugs for FDA denials, just so they could fine tune it for approval later. Bear in mind, this coming from a man who owns a large position in RPTP should come across as “all the more credible” and entirely “genuine.”

I like CLDX, CGIX (thin), RGLS, ENZY and maybe a little ONCY.

If you want to gamble a lot, have a look at AMRN. One of their stupid drugs were cast aside by the FDA last year and is up for review RIGHT NOW. The FDA promised to give them an answer by 1/15/13. That means: the stock is either going to crater or soar within two trading days.

GOOD LUCK!

The truth is, there are many biotech stocks that I want to buy now, since they’re all running, looking all cool and stuff, showing their swagger with extreme imprudence. But I had to check myself, not once, but twice. I have enough tied up in RPTP and if I took my cash and bought another biotech hand grenade, I’d be placing myself into the hurt locker, without any means to detonate the device. I’d just be sitting there, like a paradiddle, waiting to explode.